Back to search

University of Crete (UOC)

Ίνωση και αυτοφαγία σε χρόνιες ηπατοπάθειες

Abstract

dc:description

Α. Liver fibrosis. Liver fibrosis has been extensively studied at the cellular and molecular level, but very few data exist on the final enzymatic stages of collagen synthesis (prolyl hydroxylase, PH) and degradation (matrix metalloproteinases, MMPs), particularly in primary biliary cholangitis (PBC). Aim: We studied enzyme activities in liver tissue from patients with chronic liver diseases and compared them to normal livers. 18 patients with PBC of early and late stages (Ludwig’s classification) and seven on treatment with ursodeoxycholate (UDCA) were studied and compared to 34 patients with alcoholic liver disease (ALD), 25 patients with chronic viral liver disease and five normal biopsies. Sera were available from a total of 140 patients. The tritiated water released from the tritiated proline was measured in PH assessment. 14C intact and heat-denatured collagen substrates were used to measure collagenase and gelatinases, respectively. 3H elastin was the substrate for elastase. In serum, Elisas were used for MMP-1, TIMP-1, and TIMP-2 measurements while MMP-2 and MMP-9 were estimated by zymography. PH was significantly increased in early and late PBC. Collagenase was reduced only in the late stages (p<0.01), where the ratio PH/collagenase was increased. UDCA treatment restored values to almost normal. Gelatinases were reduced in late stages (p<0.05). In contrast to PBC and ALD fibrosis, collagen synthesis is not increased in viral fibrosis. The balance shifted towards collagen deposition due to reduced degradation. Interestingly, gelatinolytic activity is not impaired in ALD. Elastase was similar to controls in all diseases studied. TIMP-1 was reduced in early PBC and viral and alcoholic hepatitis and cirrhosis (p<0.001). On the contrary, TIMP-2 was significantly increased in both viral and alcoholic cirrhosis (p<0,0001). No other significant abnormality was found in the other patient groups. Serum MMP-1 was significantly reduced only in late PBC but not in early PBC. Reduction was also found in viral and alcoholic hepatitis and cirrhosis. On the contrary, PBC patients treated with UDCA but also patients with alcoholic fatty liver had normal values. Zymography showed that serum active MMP-2 and MMP-9 were significantly reduced in early and late PBC. Both MMP-2 and MMP-9 were significantly reduced in viral and alcoholic hepatitis and cirrhosis (p<0.0001). On the contrary, patients treated with UDCA and patients with alcoholic fatty liver had near normal values. Viral and alcoholic cirrhosis had similar to normal control values of the MMP-2 pro-enzymes as measured by Elisa in contrast to the active enzyme. Patients treated with UDCA and patients with alcoholic fatty liver on the other hand had increased MMP-9 pro-enzymes in contrast to normal active enzyme values. The present findings indicate that in chronic liver disease, the balance between collagen synthesis and collagen degradation is shifted towards collagen deposition irrespective of the underlying etiology. Increased synthesis is evident even in the early stages of PBC but the collagenolytic system is capable to counteract the increased synthesis, a fact that is lost during the late fibrotic stages of the disease. UDCA treatment, at least partially restores the balance, but further studies are required. New drugs proposed for the treatment of PBC should be checked for their action in the fibrotic enzymes. A similar mechanism was identified in ALD. Interestingly, the shift towards collagen deposition in chronic viral disease is due to suppression of the collagenolytic system and not to increased synthesis. Finally, levels of TIMP-1 are significantly decreased in both viral and alcoholic cirrhosis possibly acting as an additional mechanism to assist ECM degradation. In brief, the following conclusions can be suggested: (1) There is evidence that collagen synthesis increases in the early stages of PBC, but the collagenolytic mechanism may compensate for the increased synthesis. (2) In viral disease, fibrosis may be due to decreased degradation rather than increased synthesis. (3) The final biochemical stages of liver fibrosis may be quantitatively different according to underlying etiology. B. Enzymes related to autophagy Lysosomal enzymes are implicated in autophagy and senescence. Hepatic lysosomal enzymes have not been studied in Primary Biliary Cholangitis (PBC). We therefore quantified the activities of lysosomal hydrolases in liver tissue of PBC patients. We compared enzyme activities in liver tissue from PBC patients with normal livers. Alcoholic liver disease and chronic viral disease served as disease controls. Results: Cathepsin B1 was significantly increased in early PBC (225.1 ± 18.06 mean ± SD, p<0.0001) and reduced in later stages (66.5 ± 9.7, p=0.004, controls 130.4 ± 14.9). It was reduced in patients with extensive fibrosis such as alcoholic and viral cirrhosis (p<0.01 and p=0.004, respectively) but not in chronic hepatitis. Cathepsin D was increased in early PBC (39 × 10³ ± 4.8 SD, p<0.0001) and less so in later stages (20.1 × 10³ ± 3.9, p=0.05, controls 14.1 × 10³ ± 2.9). It was also increased in the presence of histological necro-inflammation in hepatitis. Treatment with ursodeoxycholate (UDCA) restored the abnormal values of enzymes in PBC. Lipid hydrolases mostly paralleled the changes of Cathepsins. Sequential measurements in serum of patients with acute alcoholic hepatitis showed that cathepsin B1 gradually decreases, and esterases increase as aminotransferases improve. The present findings in PBC are compatible with the presence of increased senescence or deranged autophagy or both in agreement with the proposed hypothesis for the pathogenesis of PBC. Most importantly, treatment with UDCA restores the abnormalities of the lysosomal enzymes. In the other chronic liver disease studied, cathepsin B1 activity reduction was associated with advanced fibrosis, while increased cathepsin D activity was associated and possibly was involved in necro-inflammation. Moreover, sequential measurements of cathepsin B and non-specific esterases may be useful as a marker of evolution of liver diseases but this requires additional studies. In brief, the following conclusions can be suggested: 1) The increased activity of lysosomal enzymes in early PBC are possibly on line with increased senescence. 2) Treatment with UDCA restores abnormal values. 3) In chronic liver disease, cathepsin B1 reduction is associated with fibrosis and increased cathepsin D with necro-inflammation. 4) Abnormalities of lysosomal enzymes indicate impairment of the final stage of autophagy in chronic liver disease.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tsomidis, Ioannis
  • Τσομίδης, Ιωάννης

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/57736

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tsomidis, Ioannis; Τσομίδης, Ιωάννης. Ίνωση και αυτοφαγία σε χρόνιες ηπατοπάθειες. University of Crete (UOC), 2024. http://hdl.handle.net/10442/hedi/57736